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Research into hippocampal self-regulation abilities may help determine the clinical significance of hippocampal hyperactivity
throughout the pathophysiological continuum of Alzheimer’s disease. In this study, we aimed to identify the effects of amyloid-b
peptide 42 (amyloid-b42) and phosphorylated tau on the patterns of functional connectomics involved in hippocampal downregulation.
We identified 48 cognitively unimpaired participants (22 with elevated CSF amyloid-b peptide 42 levels, 15 with elevated CSF
phosphorylated tau levels, mean age of 62.705  4.628 years), from the population-based ‘Alzheimer’s and Families’ study, with
baseline MRI, CSF biomarkers, APOE genotyping and neuropsychological evaluation. We developed a closed-loop, real-time
functional MRI neurofeedback task with virtual reality and tailored it for training downregulation of hippocampal subfield
cornu ammonis 1 (CA1). Neurofeedback performance score, cognitive reserve score, hippocampal volume, number of apolipopro-
tein e4 alleles and sex were controlled for as confounds in all cross-sectional analyses. First, using voxel-wise multiple regression
analysis and controlling for CSF biomarkers, we identified the effect of healthy ageing on eigenvector centrality, a measure of each
voxel’s overall influence based on iterative whole-brain connectomics, during hippocampal CA1 downregulation. Then, controlling
for age, we identified the effects of abnormal CSF amyloid-b42 and phosphorylated tau levels on eigenvector centrality during
hippocampal CA1 downregulation. Across subjects, our main findings during hippocampal downregulation were: (i) in the absence
of abnormal biomarkers, age correlated with eigenvector centrality negatively in the insula and midcingulate cortex, and positively
in the inferior temporal gyrus; (ii) abnormal CSF amyloid-b42 (51098) correlated negatively with eigenvector centrality in the
anterior cingulate cortex and primary motor cortex; and (iii) abnormal CSF phosphorylated tau levels (419.2) correlated with
eigenvector centrality positively in the ventral striatum, anterior cingulate and somatosensory cortex, and negatively in the pre-
cuneus and orbitofrontal cortex. During resting state functional MRI, similar eigenvector centrality patterns in the cingulate had
previously been associated to CSF biomarkers in mild cognitive impairment and dementia patients. Using the developed closed-loop
paradigm, we observed such patterns, which are characteristic of advanced disease stages, during a much earlier presymptomatic
phase. In the absence of CSF biomarkers, our non-invasive, interactive, adaptive and gamified neuroimaging procedure may
provide important information for clinical prognosis and monitoring of therapeutic efficacy. We have released the developed
paradigm and analysis pipeline as open-source software to facilitate replication studies.
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Introduction
Alzheimer’s disease poses a global threat to millions of lives
and the sustainability of public healthcare (Prince et al.,
2015). Recent progress is shifting the mainstream dual
clinic-pathological concept of Alzheimer’s disease towards
a pathophysiological ‘continuum’, with progression being
monitored in vivo through the study of CSF and PET bio-
markers (Jack et al., 2018). The study of the brain alter-
ations associated with the presence of abnormal levels of
biomarkers in unimpaired individuals may shed light on
factors and mechanisms associated with cerebral resilience
or vulnerability to early Alzheimer’s disease pathology.
According to the ‘compensation-related utilization of
neural circuits hypothesis’ (CRUNCH; Reuter-Lorenz and
Cappell, 2008) and the ‘network-based degeneration’
theory (Seeley et al., 2009), functional alterations such as
hippocampal hyperactivity during the preclinical stage are
likely to be initially compensated by specific changes in
functional connectomics (Jacobs et al., 2013). In network
science, eigenvector centrality (EC) is one of the most
advanced connectomic metrics (Bonacich, 1972; Langville
and Meyer, 2006) that is designed to reflect the influence of
each node on the overall connectomic patterns of a net-
work (Borgatti, 2005; Lohmann et al., 2010; Wink et al.,
2012). For example, when applied to social interactions,
EC can determine the members of a social network exerting
the most influence (Bonacich, 1972) and EC is also the
metric subserving the most successful internet search
engine (Langville and Meyer, 2006). In functional neuro-
imaging, eigenvector centrality mapping (ECM) is an
assumption-free, data-driven procedure that can be per-
formed in high image resolution, for each participant,
using the time series from every individual voxel while
accounting for global brain patterns of functional connect-
ivity. ECM derives estimates of relative influence on whole
brain connectomics, per voxel or cluster of voxels
(Lohmann et al., 2010; Wink et al., 2012). Importantly,
EC values can be processed to meet parametric assump-
tions, enabling group-level regression with biomarker cov-
ariates to be performed. These features make ECM
particularly promising for the investigation of changes
along disease continuums such as the pathophysiological
continuum of Alzheimer’s disease (Skouras et al., 2019a).
Previous studies have shown that EC reveals similar pat-
terns to fluorodeoxyglucose (FDG)-PET when comparing pa-
tients with Alzheimer’s disease to healthy controls
(Adriaanse et al., 2016), and that patients with Alzheimer’s
disease present significant differences in EC, in the anterior
cingulate cortex (ACC), paracingulate gyrus, cuneus and oc-
cipital cortex (Binnewijzend et al., 2014). An independent
study found that increased EC in the cingulate cortex and
thalamus is related to compensatory mechanisms across the
pathophysiological continuum of Alzheimer’s disease, and
evidenced a relation of these EC patterns to reduced func-
tional connectivity between the midcingulate cortex and the
left hippocampus during the preclinical phase of Alzheimer’s
disease (Skouras et al., 2019a). The latter finding suggested
that EC changes may comprise a sensitive indicator of pre-
clinical changes in functional connectomics related to hippo-
campal function. However, all previous investigations of EC
in Alzheimer’s disease have been limited to task-free (i.e.
resting state) functional MRI, even though EC is particularly
suited for the explorative investigation of differences in task-
related connectivity with functional MRI designs featuring
long, continuous experimental conditions (Koelsch and
Skouras, 2014; Alnæs et al., 2015). Recent evidence suggests
that functional tasks that engage specific brain regions af-
fected by a disease lead to stronger effects and consequently
to higher discriminative power between patients and controls
(Finn et al., 2017; Greene et al., 2018). In the present study,
we aimed to investigate preclinical differences of EC related
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to hippocampal function, by harnessing the sensitivity of
CSF biomarkers.
Across Alzheimer’s disease patient studies and healthy
memory studies, the hippocampus has been established to
be the single brain region with the most important role
(Schwindt and Black, 2009; Kim, 2011). Hippocampal sub-
field CA1 in particular, appears to be a region that is in-
tegral to contextual episodic memory (Mizumori et al.,
1999; Leutgeb et al., 2004; Vazdarjanova and Guzowski,
2004; Penner and Mizumori, 2012). CA1 presents atrophy
linked to Alzheimer’s disease pathology but no volume loss
related to normal ageing (Wilson et al., 2004; Frisoni et al.,
2008; Yushkevich et al., 2015). Here, we focus on hippo-
campal subfield CA1 because we reasoned that if preclinical
alterations in brain function indeed occur prior to neuro-
degeneration as has been suggested (Pihlajamäki and
Sperling, 2008; Teipel et al., 2015), it is probable that
they are most prominent in areas that later undergo atro-
phy due to Alzheimer’s disease. Hippocampal hyperactivity
appears to precede amyloid accumulation (Leal et al.,
2017), which is accepted as the earliest sign of preclinical
Alzheimer’s disease (Jack et al., 2018). Hippocampal hyper-
activity also appears to be more prominent in subjects at
genetic risk for Alzheimer’s disease (Tran et al., 2017). The
lack of concurrent neurodegeneration or decline in cogni-
tive performance (Leal et al., 2017; Tran et al., 2017)
implies: (i) that hippocampal hyperactivity is the result of
compromised neural efficiency, as defined in the context of
neural reserve (Barulli and Stern, 2013; Stern et al., 2018);
and (ii) a potential link between hippocampal hyperactivity
and compromised hippocampal downregulation abilities. In
this context, developing a standard framework for the in-
vestigation of the ability to downregulate hippocampal ac-
tivation may bring us a step closer to detecting Alzheimer’s
disease-specific signs earlier along the pathophysiological
continuum of Alzheimer’s disease.
Real-time neurofeedback enables focusing investigations
on specific brain regions and their self-regulation during
interactive functional tasks (Sitaram et al., 2017).
Neurofeedback with real-time functional MRI (rt-fMRI) is
particularly suited to study hippocampal downregulation
due to the spatiotemporal resolution of functional MRI
and the deep-brain location of the hippocampus. In a pre-
vious rt-fMRI neurofeedback study of healthy young
adults, memory performance correlated with downregula-
tion, but not upregulation, of the parahippocampal forma-
tion (Weiskopf et al., 2004). Moreover, a recent study has
demonstrated that rt-fMRI neurofeedback is suitable for
the downregulation of deep-brain structures (e.g. the amyg-
dala that is adjacent to the hippocampus), as well as a link
between amygdala downregulation and clinical symptoms
(Nicholson et al., 2017). In addition, neurofeedback tasks
can be combined with virtual reality (VR). VR has shown
promise for the development of immersive experimental
tasks with increased ecological validity (Krokos et al.,
2018), which have revealed significant insights regarding
hippocampal function (Duarte et al., 2014; Igloi et al.,
2014; Dimsdale-Zucker et al., 2018). Furthermore, VR
promotes participants’ experimental compliance, through
perceptual immersion in engaging tasks (Chirico et al.,
2017) that in turn can result in higher engagement
(Torner et al., 2019) and improved performance (Krokos
et al., 2018). The increased engagement and compliance
afforded by VR tasks, facilitates focused participation in
long functional tasks. Combined with closed-loop neuro-
feedback paradigms, long tasks enable the acquisition of
continuous whole-brain datasets that are optimal for the
reliable estimation of functional connectomics (Gonzalez-
Castillo et al., 2014; Finn et al., 2015), including EC.
Here, we fused state-of-the-art, disruptive technologies
(i.e. fully automated electrochemiluminescence immuno-
assay, real-time functional neuroimaging and VR), aiming
to create an interactive and entertaining task to investigate
the neural correlates of hippocampal downregulation, asso-
ciated with core Alzheimer’s disease CSF biomarkers and
healthy ageing, in a sample of cognitively unimpaired par-
ticipants at risk for Alzheimer’s disease. We hypothesized
that: (i) to downregulate hippocampal activation, partici-
pants with hippocampal hyperactivity engage their brain
differently or more strongly than healthy agers and that
such differences can be captured by EC during hippocam-
pal downregulation; and (ii) we may identify patterns of
functional connectomics during hippocampal downregula-
tion that resemble those found during resting state at
advanced Alzheimer’s disease stages. Specifically, we ex-
pected to find measurable differences of EC in the occipital
cortex (Binnewijzend et al., 2014), the inferior parietal
lobule, the thalamus and the cingulate cortex
(Binnewijzend et al., 2014; Skouras et al., 2019a).
Materials and methods
Participants
Participants comprised of 48 adult volunteers with complete
data [mean age = 62.705 years; standard deviation (SD) =
4.628] from the ongoing ALFA (Alzheimer’s and Families)
project and related substudies, many of them descendants of
patients with Alzheimer’s disease and APOE e4 allele carriers,
hence presenting increased risk for Alzheimer’s disease
(Molinuevo et al., 2016). All data were acquired at the
Barcelonabeta Brain Research Center, from 2016–18.
Researchers were blind to biomarker levels and cognitive per-
formance during data acquisition. All participants were highly
functional and without neurological or psychiatric history at
the time of scanning, as assessed in the medical baseline ses-
sion of their ongoing ALFA-related study within the previous
12 months (time between baseline ALFA and rt-fMRI scan-
ning: mean = 6.4 months, SD = 2.5). The cognitively unim-
paired status of participants was also assessed as an inclusion
criterion in the cognitive testing session of their ongoing
ALFA-related study within the previous 12 months (mean =
6.4 months, SD = 2.5), according to their scores on the
Clinical Dementia Rating scale (CDR = 0; Hughes et al.,
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1982; Morris, 1993) and the Mini-Mental State Examination
(MMSE 5 27; Folstein et al., 1975; Blesa et al., 2001). During
that cognitive testing session, participants also completed the
Free and Cued Selective Reminding Test (FCSRT; Grober
et al., 2009), the Subjective Cognitive Decline Questionnaire
(SCD-Q; Rami et al., 2014) and the Visual Puzzles test
included in the Wechsler Adult Intelligence Scale IV (WAIS
IV; Weschler, 2013); all scores are summarized in Table 1.
The FCSRT is an internationally standardized research instru-
ment recommended for the assessment of episodic memory
and diagnosis of prodromal Alzheimer’s disease (Dubois
et al., 2007, 2014). The SCD-Q is a useful tool to measure
self-perceived cognitive decline, independently of a partici-
pant’s objective neuropsychological assessment. According to
their SCD-Q responses, four participants had a subjective im-
pression of cognitive or memory decline, while their cognition
was preserved based on objective cognitive testing (see
‘Discussion’ section). The Visual Puzzles test measures non-
verbal reasoning and the ability to analyse and synthesize ab-
stract visual stimuli. It is related to visual perception, general
visuospatial intelligence, fluid intelligence, simultaneous pro-
cessing, visualization and spatial manipulation, as well as the
ability to anticipate relationships between constituent parts of
a whole. Within a given time limit (either 20 or 30 s, depend-
ing on the complexity of a puzzle), the participant was in-
structed to select the three pieces necessary for the
reconstruction of the presented puzzle. Each item is scored
with 0 or 1 and the testing is suspended after three consecutive
scores of 0. The test consists of 26 items and the estimated
administration time is 10 min. At inclusion of participants in
the ALFA project, they had also completed the Cognitive
Reserve Questionnaire (CRQ; Supplementary Table 1); a ques-
tionnaire comprising eight questions whose total score serves
as a proxy for cognitive reserve (Rami et al., 2011). To assess
core Alzheimer’s disease biomarker levels in CSF, participants
underwent lumbar puncture within the preceding 10 months
(time between lumbar puncture and rt-fMRI scanning: mean =
5.23 months, SD = 2.49). Eighteen participants presented
normal CSF biomarkers (amyloid-b42 levels 4 1098 pg/ml
and p-tau levels 5 19.2 pg/ml), 22 participants presented
CSF amyloid-b42 levels 5 1098 pg/ml, 15 participants pre-
sented CSF p-tau levels 4 19.2 pg/ml and seven of the latter
met both criteria. Participants did not differ significantly with
regards to any cognitive or neuroimaging variables, regardless
of grouping based on CSF amyloid-b42 and p-tau levels
(Table 1). Thorough quality control was applied in advance,
to exclude five datasets with410% invalid functional volumes
due to movement, as well as seven datasets with rt-fMRI ac-
quisitions during which technological complications occurred
and six datasets with rt-fMRI acquisitions during which fa-
tigue, discomfort or sleep had occurred. The local ethics com-
mittee ‘CEIC-Parc de Salut Mar’ reviewed and approved the
study protocol and informed consent form, in accordance with
current legislation.
CSF sampling
CSF was collected by lumbar puncture between 9 and 12 am
in polypropylene tubes. Samples were processed within 1 h
and centrifuged at 4C for 10 min at 2000g, stored in poly-
propylene tubes and frozen at –80C. Core Alzheimer’s disease
CSF biomarkers (namely amyloid-b42 and p-tau) were deter-
mined using cobas Elecsys assays (Hansson et al., 2018).
APOE genotyping
Proteinase K digestion and subsequent alcohol precipitation
was used to obtain DNA from the blood cellular fraction.
Samples were genotyped for two single nucleotide polymorph-
isms (rs429358 and rs7412) and the number of APOE e4
alleles was determined for each participant (Molinuevo et al.,
2016). Results are displayed in Table 2.
Image acquisition
All scanning was performed in a single 3 T Philips Ingenia CX
MRI scanner (2015 model). Pre-neurofeedback scanning com-
prised a 3D T1-weighted sequence of 240 sagittal slices with
voxel resolution = 0.75  0.75  0.75 mm3, repetition time =
9.90 ms, echo time = 4.60 ms, flip angle = 8; and a diffusion-
weighted sequence of 66 axial slices with voxel resolution =
2.05  2.05  2.20 mm3, repetition time = 9000 ms, echo
time = 90 ms, flip angle = 90, featuring 72 non-collinear dir-
ections (b = 1300 s/mm2) and one non-gradient volume (b = 0
s/mm2). During neurofeedback, echo planar imaging was used
with voxel resolution = 3  3  3 mm3, repetition time =
3000 ms, echo time = 35 ms, matrix size = 80  80 voxels,
field of view = 240 mm and interleaved slice acquisition with
an interslice gap of 0.2 mm (45 slices, whole brain coverage).
In total, 610 functional volumes were acquired.
Structural image processing
The standard FreeSurfer pipeline was applied on T1-weighted
images to estimate each participant’s normalized hippocampal
brain volume, as a proxy of brain reserve, by dividing total
hippocampal volume by total intracranial volume (Cavedo
et al., 2012). Using the Advanced Normalization Tools
(Avants et al., 2009) (ANTs v2.x; RRID: SCR_004757), the
N4 non-parametric non-uniform intensity normalization bias
correction function (Tustison et al., 2010; Tustison and
Avants, 2013) was applied on all T1 images, followed by an
optimized blockwise non-local means denoising filter (Coupé
et al., 2008). Multi-atlas segmentation with joint label fusion
(Wang et al., 2013) segmented hippocampal subfields to derive
probabilistic maps for CA1, which were thresholded at P = 0.9
to create the neurofeedback target region of interest masks.
Experimental paradigm
The design of the VR paradigm was guided by the following
objectives: (i) we used VR to make the task immersive, enga-
ging and entertaining, which in turn; (ii) enabled us to extend
the task to 30 min to maximize first-level statistical power; (iii)
we used sliding-window closed-loop neurofeedback to achieve
an optimal design for analysis of functional connectomics; and
(iv) we narrowed the neurofeedback target region of interest to
hippocampal subfield CA1, which presents atrophy in
Alzheimer’s disease but not in healthy ageing (Wilson et al.,
2004; Frisoni et al., 2008; Yushkevich et al., 2015), while also
being consistently implicated in memory encoding (Kim, 2011)
and differing in activity in patients (Schwindt and Black,
2009). Prior to the acquisition of CSF biomarkers, the task
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Table 1 Descriptive and comparative statistics, across groupings based on CSF amyloid-b42 and p-tau levels
Entire sample Controls Amyloid-b42 5 1098 p-tau 4 19.2 PreAD
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
n; M / F 48; 21 / 27 18; 7 / 11 22; 10 / 12 15; 8 / 7 7; 4 / 3
Age 62.705 (4.628) 62.143 (4.690) 62.143 (5.171) 65.051 (2.306) 64.919 (3.202)
t = –0.099 t = 2.070 t = 1.352
P = 0.921 P = 0.046 P = 0.193
Ab42 1186.200 (424.678) 1492.111 (232.529) 795.123 (232.529) 1189.60 (454.94) 771.06 (190.47)
t = –9.677 t = –2.423 t = –7.636
P 5 0.001 P = 0.022 P 5 0.001
p-Tau 18.233 (9.007) 14.735 (3.046) 16.645 (8.190) 28.624 (8.819) 26.513 (6.554)
t = 0.936 t = 6.265 t = 6.221
P = 0.367 P 5 0.001 P 5 0.001
t-Tau 220.273 (86.623) 1.906 (37.090) 1984.318 (73.441) 318.133 (81.981) 285.071 (55.774)
t = 0.410 t = 5.925 t = 4.959
P = 0.687 P 5 0.001 P 5 0.001
p-Tau / Ab42 0.017 (0.010) 0.010 (0.002) 0.023 (0.012) 0.027 (0.011) 0.035 (0.009)
t = 4.584 t = 6.460 t = 12.051
P 5 0.001 P 5 0.001 P 5 0.001
FCSRT Total recall 44.292 (3.989) 43 (5.053) 45.091 (3.054) 45 (2.619) 45 (2.082)
t = 1.616 t = 1.384 t = 1.004
P = 0.117 P = 0.192 P = 0.348
FCSRT Retention Index 0.980 (0.066) 0.980 (0.077) 0.981 (0.055) 0.976 (0.058) 0.973 (0.033)
t = 0.036 t = –0.171 t = –0.219
P = 0.959 P = 0.871 P = 0.833
FCSRT Delayed cued recall 3.708 (1.675) 3.667 (1.910) 3.454 (1.683) 3.867 (1.552) 3.429 (1.902)
t = –0.373 t = 0.325 t = –0.280
P = 0.725 P = 0.768 P = 0.818
FCSRT Delayed free recall 11.479 (1.935) 11.222 (2.315) 12 (1.746) 11.467 (1.652 12 (2)
t = 1.211 t = 0.343 t = 0.780
P = 0.246 P = 0.796 P = 0.491









FCSRT Total cued recall 15.729 (4.409) 15.111 (4.071) 15.545 (4.426) 16.733 (4.061 18.143 (4.413)
t = 0.320 t = 1.141 t = 1.635
P = 0.767 P = 0.270 P = 0.122
FCSRT Total delayed recall 15.187 (1.214 14.889 (1.323) 15.454 (0.800) 15.333 (0.816) 15.429 (0.534)
t = 1.669 t = –0.298 t = 1.035
P = 0.109 P = –1.132 P = 0.378


















Years of education 13.750 (3.778 ) 13.444 (3.959) 13.727 (3.588) 13.800 (3.950) 13.000 (3.697)
t = 0.237 t = 0.830 t = –0.256
P = 0.832 P = 0.257 P = 0.819
Hippocampal volume / TIV 0.005 (0.001) 0.005 (0.001) 0.005 (0.001) 0.005 (0.001) 0.005 (0.001)
t = 0.444 t = 0.555 t = –0.1865
P = 0.665 P = 0.587 P = 0.854
Hippocampal downregulation NF score –0.038 (0.462) –0.098 (0.437) –0.049 (0.473) 0.0475 (0.524) –0.043 (0.568)
t = 0.334 t = 0.871 t = 0.259
P = 0.743 P = 0.386 P = 0.796
Mean EC in CA1 0.282 (0.040) 0.290 (0.037) 0.272 (0.043) 0.283 (0.043) 0.277 (0.054)
t = –1.383 t = –0.497 t = –0.717
P = 0.178 P = 0.622 P = 0.486
Ab42 = amyloid-b42; CRQ = Cognitive Reserve Questionnaire; F = Female; FSCRT = Free and Cued Selective Reminding Test; M = male; NF = neurofeedback; PreAD = preclinical
Alzheimer’s disease; t = average t-statistic from 10 000 non-parametric permutation tests, comparing each category to controls; TIV = total intracranial volume.
Asterisks denote uncorrected significance at conventional alpha levels.







aa011/5753887 by guest on 25 February 2020
was validated in a larger partly independent sample (77%
overlap), by showing that hippocampal downregulation was
associated with genetic predisposition to Alzheimer’s disease,
neurodevelopmental processes and bilateral cohesion of hippo-
campal function (Skouras et al., 2019b).
The VR environment had been developed in the game-
engine Unity (Unity Technologies ApS, San Francisco, USA)
(Fig. 1). During a 30-min long scanning session, participants
were immersed in the VR environment and could run in a
fixed, circular path. The experimental task was to explore
different mental strategies, aiming to achieve the maximum
velocity and to traverse the maximum distance possible, while
at the same time attending to features of the VR environment,
remembering them and considering whether they changed be-
tween each lap of the environment. Debriefing interviews re-
vealed that most participants tried similar simple strategies,
such as internal self-motivational speech, imagining that they
were on a speeding vehicle, or focusing their sight on a spe-
cific point in the field of view. The first 30 functional volumes
of the session served to establish a baseline of hippocampal
activity, for each participant. Subsequently, with every repe-
tition time, the most recent shift in hippocampal CA1 activity
was compared to reference measures of change derived from
the preceding 90 s (30 functional volumes; see ‘Online func-
tional image processing and neurofeedback’ section). A 5%
decrease of VR velocity was triggered by increases in hippo-
campal activity and a 5% increase of velocity was triggered
by decreases in hippocampal activity. At any given moment,
the current velocity was displayed as a percentage of the
maximum velocity possible and a green or red signal was
superimposed on a coronal brain view, reflecting the direction
of the most recent change (Fig. 1). Every 30 volumes, the
velocity was reset to 50%, resulting in 19 trials per session.
The trials were not related to the experimental design from a
statistical perspective, because computing EC requires hun-
dreds of continuous functional volumes; however, having dis-
tinct trials served three important purposes. First, by resetting
the speed every 90 s, all participants had a similar gamified
experience, regardless of their actual performance. This was
important from an ethical perspective because participants
were aware that the gamified task, even though experimental,
could be reflecting aspects of their brain function and health.
It was therefore important that all participants would exit
from the scanning session with an overall positive experience
(and without any reason to worry) and this was also a sec-
ondary motivation to implement an online analysis pipeline
with adaptive difficulty, based on a sliding-window baseline
(see ‘Online functional image processing and neurofeedback’
section). Second, by resetting the speed and adapting the dif-
ficulty of the task, all participants had a similar overall sen-
sory and perceptual experience. This was important to
control for the effects of potential confounding factors such
as individual differences in visual cortex activity during the
scanning sessions. Third, resetting the speed enabled the de-
veloped paradigm to utilize effectively the basic principles of
operant conditioning and sensory-aided learning. Because in
the context of the gamified goal accelerations are perceived to
be of positive valence and decelerations are perceived to be of
negative valence, the 570 neurofeedback signals that occurred
during each 30-min scanning session acted as positive and
negative reinforcers, respectively. Thus, resetting the speed
at regular intervals was necessary to avoid ceiling or floor
effects that could compromise the number of reinforcers pro-
duced in a particular session.
Online functional image processing
and neurofeedback
In each rt-fMRI session, EPI (echo planar imaging) images of
whole-brain activity were acquired, reconstructed and ex-
ported every 3 s. The first 10 functional volumes were dis-
carded to allow for gradient and tissue excitation levels to
stabilize (Soares et al., 2016). Online movement correction
through rigid-body registration was performed relative to an
initial reference volume. To remove low frequency drifts in the
functional MRI time series, temporal high-pass filltering with a
cut-off frequency of 1/200 Hz (Tarvainen et al., 2002) was
applied in real-time. An initial baseline mean and standard
deviation were computed based on the first 30 processed func-
tional volumes, during which the VR movement velocity re-
mained constant at 0.5. Subsequently, voxel-efficiency
weighting (Stoeckel et al., 2014) was performed by normal-
izing new images based on the mean and standard deviation






where, at time t;Xt represents the filtered value of a single
voxel, X t301ð Þ:ðt1Þ represents the mean of that voxel’s time
series within a time-window of 30 volumes up to time ðt  1Þ,
 t301ð Þ: t1ð Þ represents the corresponding standard deviation
and zt represents the efficiency-weighted value of the voxel.
The length of the sliding window was set to 30 as a trade-
off between the speed of adaptation and the reliability of the
mean estimates, in accordance with generic statistical guide-
lines and the central limit theorem (Hogg et al., 1977). For
each acquired functional volume, an outcome variable was
instantiated for the activity measured within each participant’s
hippocampal CA1 region of interest, in native space, based on
the following computations. At any given time point t0, a
voxel-wise expected data vector Y was computed according
to Equation 2.






where Z tÞð represents the voxel-wise observed data vector
comprised of the output of Equation 1 for all voxels within
the region of interest at time t. A non-linear metric neurofeed-
back metric (NF) was computed for each new volume, in real-
time, according to Equation 3.
NF ¼ Z t0ð Þ  Y t0ð Þ ð3Þ
With every repetition time, if the average expected signal sur-
passed the average observed signal in the hippocampal CA1
region of interest, the velocity v in the VR environment
increased by 5% according to Equation 4; in the opposite
case, the velocity decreased by 5% according to Equation 5,
where v represents the VR movement velocity in the range
{0.1, 1}.
NF50! v ¼ 0:05 ð4Þ
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NF40! v ¼ 0:05 ð5Þ
Offline functional image processing
Raw images were processed and examined using a well-con-
trolled combination of highly specialized functions from
open-source neuroimaging software. To maximize cortical seg-
mentation accuracy, T1 images were subjected to the N4 non-
parametric non-uniform intensity normalization bias correction
function (Tustison et al., 2010, 2013) of the Advanced
Normalization Tools (ANTs; version 2.x, committed in
January 2016; Avants et al., 2009) and to an optimized
blockwise non-local means denoising filter (Coupé et al.,
2008). SPM12 (Statistical Parametric Mapping, RRID:
SCR_007037) together with VBM8 (VBM toolbox, RRID:
SCR_014196), were used to segment each anatomical image
into grey matter, white matter and CSF. Whole-brain images
with removed cranium were also derived and used for normal-
ization. Neuroanatomically-plausible symmetric diffeomorphic
matrices were computed to transform each subject’s anatom-
ical data to a custom template derived from the same popula-
tion (Skouras et al., 2019a) and subsequently to MNI space
(Avants et al., 2011; Tustison and Avants, 2013) as defined by
the robust, high-definition ICBM (International Consortium
for Brain Mapping) brain template (Fonov et al., 2011), also
with removed cranium. All transformation matrices were con-
catenated and applied to the CA1 region of interest masks and
functional MRI datasets in a single step to ensure optimal
normalization while avoiding multiple interpolations, in ac-
cordance with best image processing practices.
Using SPM12 and the MIT connectivity toolbox
(Connectivity Toolbox, RRID: SCR_009550), functional data
were subjected to standard preprocessing, consisting of
Table 2 Assessment of non-collinearity between measured variables
Age Amyloid-b42 p-tau T-tau p-tau/amyloid-b42
Age – R = 0.129 R = 0.369 R = 0.373 R = 0.224
P = 0.382 P = 0.010 P = 0.009 P = 0.126
Amyloid-b42 R = 0.129 – R = 0.195 R = 0.276 R = –0.580
P = 0.382 P = 0.184 P = 0.057 P 5 0.001
P-tau R = 0.369 R = 0.195 – R = 0.987 R = 0.625
P = 0.010 P = 0.184 P 5 0.001 P 5 0.001
T-tau R = 0.373 R = 0.276 R = 0.987 – R = 0.553
P = 0.009 P = 0.057 P 5 0.001 P 5 0.001
P-tau / amyloid-b42 R = 0.224 R = –0.580 R = 0.625 R = 0.553 –
P = 0.126 P 5 0.001 P 5 0.001 P 5 0.001
APOE e4 allele carrier status R = –0.699 R = –0.325 R = –0.288 R = –0.290 R = 0.025
P 5 0.001 P = 0.024 P = 0.047 P = 0.046 P = 0.864
FCSRT Total recall R = –0.177 R = –0.202 R = 0.004 R = 0.014 R = 0.125
P = 0.227 P = 0.168 P = 0.976 P = 0.921 P = 0.398
FCSRT Retention Index R = 0.088 R = 0.065 R = –0.046 R = –0.015 R = –0.083
P = 0.554 P = 0.658 P = 0.756 P = 0.921 P = 0.576
FCSRT Delayed cued recall R = 0.250 R = –0.026 R = 0.143 R = 0.107 R = 0.156
P = 0.087 P = 0.861 P = 0.331 P = 0.468 P = 0.291
FCSRT Delayed free recall R = –0.217 R = –0.087 R = –0.129 R = –0.090 R = –0.073
P = 0.138 P = 0.558 P = 0.383 P = 0.543 P = 0.621
FCSRT Total free recall R = –0.307 R = 0.016 R = –0.128 R = –0.089 R = –0.137
P = 0.033 P = 0.913 P = 0.387 P = 0.547 P = 0.353
FCSRT Total cued recall R = 0.239 R = –0.219 R = 0.175 R = 0.133 R = 0.305
P = 0.101 P = 0.134 P = 0.233 P = 0.369 P = 0.035
FCSRT Total delayed recall R = 0.004 R = –0.197 R = –0.005 R = 0.008 R = 0.114
P = 0.978 P = 0.180 P = 0.974 P = 0.956 P = 0.439
WAIS IV Visual Puzzles Total Score R = –0.397 R = 0.092 R = –0.112 R = –0.106 R = –0.190
P = 0.005 P = 0.535 P = 0.447 P = 0.475 P = 0.196
CRQ score R = –0.012 R = 0.046 R = 0.013 R = 0.025 R = –0.081
P = 0.935 P = 0.755 P = 0.927 P = 0.868 P = 0.582
Years of education R = –0.208 R = –0.018 R = –0.137 R = –0.118 R = –0.091
P = 0.156 P = 0.901 P = 0.354 P = 0.424 P = 0.540
Hippocampal volume / TIV R = –0.026 R = –0.012 R = 0.044 R = 0.068 R = –0.025
P = 0.859 P = 0.933 P = 0.764 P = 0.645 P = 0.864
Hippocampal downregulation NF score R = 0.219 R = 0.087 R = 0.215 R = 0.198 R = 0.115
P = 0.135 R = 0.557 P = 0.143 P = 0.176 P = 0.434
Mean EC in CA1 R = 0.164 R = 0.219 R = –0.019 R = 0.017 R = –0.172
P = 0.264 P = 0.135 P = 0.898 P = 0.908 P = 0.242
CRQ = Cognitive Reserve Questionnaire; FSCRT = Free and Cued Selective Reminding Test; NF = neurofeedback; TIV = total intracranial volume.
Asterisks denote uncorrected significance at conventional alpha levels.
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slice-time correction, realignment and reslicing of functional vol-
umes, denoising via regression of average white matter timeseries,
average CSF timeseries, 24 Volterra expansion movement param-
eters and scan-nulling regressors (Lemieux et al., 2007) produced
by the Artifact Detection Tools (ART; RRID: SCR_005994).
Each subject’s functional data were masked by the grey matter
of their equivalent anatomical datasets using FSL and then
normalized to MNI space in accordance with their respective
diffeomorphic matrices using ANTs. Temporal high-pass filtering
with a cut-off frequency of 1/90 Hz and spatial smoothing using
a 3D Gaussian kernel and a filter size of 6 mm full-width at half-
maximum, were performed using the Leipzig Image Processing
and Statistical Inference Algorithms (LIPSIA v2.2.7, 2011,
RRID: SCR_009595; Lohmann et al., 2000).
Figure 1 VR environment and neuroimaging pipeline. The VR neurofeedback paradigm developed for the study used principles of
passive, sensory-aided, operant conditioning and featured 570 neurofeedback signals per session. To maintain a balanced perceptual experience
across participants, task difficulty adapted to individual performance dynamically, aiming to drive CA1 activity in each participant to the minimum
possible. Using previously acquired anatomical images, multi-atlas hippocampal subfield segmentation localized and segmented hippocampal
subfield CA1, prior to real-time scanning. With every real-time functional volume, moment-to-moment changes in hippocampal CA1 activation
effected inverse changes of velocity in VR. Offline statistical modelling was used to derive a measure of neurofeedback regulation performance and
to perform EC mapping (i.e. to estimate how much influence each voxel exerts during hippocampal CA1 downregulation with neurofeedback).
APOE = apolipoprotein genotype; Ab42 = amyloid-b42; BrainRes = brain reserve; CA1 = cornu ammonis 1; CogRes = cognitive reserve; fMRI =
functional MRI; GLM = general linear model; NF = neurofeedback; p-tau = phosphorylated tau; ROI = region of interest; TIV = total intracranial
volume.
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EC was computed for every voxel, based on the LIPSIA im-
plementation of ECM (vecm command), with previously pub-
lished detailed mathematical specification (Lohmann et al.,
2010). In effect, the ECM procedure begins by computing a
correlation coefficient between every possible pair of voxels
within the computational volume (e.g. grey matter mask),
based on their time series. It then assigns to each voxel an
initial centrality value that is computed as the sum of all cor-
relation coefficients that exist between that voxel and all other
voxels (a value equivalent to degree centrality). Subsequently,
ECM updates the centrality value in each voxel iteratively,
each time by a weighted sum of its correlation coefficients
with other voxels, using weights that correspond to each
paired voxel’s centrality value from the previous iteration.
The iterations repeat until the values stabilize and there is no
further change from one iteration to the next. Importantly, we
limited the similarity matrix to positive correlations between
grey matter voxels, similarly to our previous Alzheimer’s dis-
ease study with EC (Skouras et al., 2019a). EC values were
Gaussianized voxel-wise across all subjects to enable second-
level parametric inference, using a general transformation de-
signed to optimize the reliability of arbitrary distributions
(Albada and Robinson, 2007). The resulting whole-brain
images entered second level statistical modelling and voxel-
wise multiple regression analyses (see ‘Statistical analysis’
section).
Statistical analysis
For standard type I and II error rates ( = 0.05, b = 0.20), a
priori computations of required sample size were performed
using statistical power estimation software (GPower v 3.1;
RRID: SCR_013726; Faul et al., 2007, 2009). The computa-
tions suggested that to enable sufficient statistical power for
effects of medium size (f2 4 0.15), using multiple regression
with up to seven predictor variables, a minimum sample size of
43 subjects would be required. Pearson’s r was used as a
metric of similarity in first-level general linear model (GLM)
to quantify neurofeedback performance per participant. A
linear vector coding continuous downregulation, as the target
performance for neurofeedback, was compared to neurofeed-
back moment-to-moment regulation, measured by the re-
aligned average CA1 time series, to produce a measure of
neurofeedback performance for each participant similar to a
previous study (Skouras and Scharnowski, 2019). First, we
investigated whether the unique variance associated with CSF
amyloid-b42 levels was reflected in EC during the neurofeed-
back task. For consistency, CSF amyloid-b42 values were mul-
tiplied by –1 during modelling, to align results and colour
maps with the direction of the pathophysiological continuum
of Alzheimer’s disease. CSF amyloid-b42 values were orthogo-
nalized to potential confounding variables; specifically sex,
age, number of APOE e4 alleles, hippocampal volume, cogni-
tive reserve and neurofeedback performance. This resulted in
an orthogonal second-level design matrix that was used for
GLM of the unique effect of amyloid-b42 on EC during VR
neurofeedback. The resulting whole-brain z-map was corrected
for multiple comparisons using 10 000 iterations of Monte
Carlo simulations, with a pre-threshold of z 4 2.326 (P 5
0.01) and a corrected significance level of P 5 0.05.
Similarly, we investigated for a possible correlation between
p-tau and EC, controlling for the same confounding variables.
Finally, we investigated the effect of healthy ageing on EC
during VR neurofeedback, by orthogonalizing age to all po-
tential confounding factors, including the CSF p-tau by amyl-
oid-b42 ratio (Maddalena et al., 2003). All second-level
neuroimaging analyses featured data from the entire sample.
All scale variables were normalized prior to orthogonalization
via the recursive Gram-Schmidt orthogonalization of SPM12
(SPM, RRID: SCR_007037). For quality control, we confirmed
that each variable of interest was completely orthogonal to all
covariates in its respective design matrix, as well as to all ori-
ginal vector data, while remaining in high correlation with its
own original vector. This ensured investigating meaningful ob-
servations and effects due to the unique variance in each vari-
able of interest.
Code and data availability
The VR environment and the analysis software developed for
the experiment, are publicly available as open-source software
via the ‘VR_multipurpose_v1.0’ and the ‘HippDownReg_exp1’
repositories (GitHub; RRID: SCR_002630), respectively. Data
used can been made available to researchers for non-commer-
cial purposes, following agreement and approval by the




Controlling for the effects of age, sex, number of APOE e4
alleles, hippocampal volume, cognitive reserve and neuro-
feedback performance, CSF amyloid-b42 levels showed a
significant positive correlation with EC in the ACC
[Brodmann area (BA)24, BA32] and primary motor
cortex (BA4) (Fig. 2 and Table 3). Note that amyloid-b42
levels in CSF are inversely proportional to the extent of
amyloid-b plaque accumulation in the brain (Strozyk
et al., 2003; Grothe et al., 2017); i.e. abnormal amyloid-
b42 biomarkers were related to low EC in the ACC and
BA4.
Phosphorylated-tau
Controlling for the effects of age, sex, number of APOE e4
alleles, hippocampal volume, cognitive reserve and neuro-
feedback performance, p-tau levels in CSF showed a signifi-
cant positive correlation with EC in the ACC (BA32, BA10)
ventral striatum (caudate, nucleus accumbens, putamen)
and left primary somatosensory cortex (BA2). CSF p-tau
levels, also showed a significant negative correlation with
EC in the posterior cingulate cortex, precuneus, cuneus and
left frontal pole (BA9) (Fig. 3 and Table 3).
Healthy ageing
Controlling for the effects of sex, number of APOE e4
alleles, hippocampal volume, cognitive reserve,
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neurofeedback performance and the CSF p-tau by amyloid-
b42 ratio (Maddalena et al., 2003), age presented a signifi-
cant negative correlation with EC in the midcingulate
cortex, insula, primary somatosensory cortex (BA2) and
inferior parietal lobule (BA40). Age also presented a signifi-
cant positive correlation with EC in the inferior temporal
gyri (Fig. 4 and Table 3).
Discussion
Adding to our knowledge, this is the first real-time neuro-
feedback study using CSF biomarker data. The results in
cognitively unimpaired participants at risk for Alzheimer’s
disease corroborate that differences of EC in the cingulate
cortex play an important role in the pathophysiological
continuum of Alzheimer’s disease and show for the first
time that such differences may begin at a very early patho-
physiological stage. The latter finding suggests that hippo-
campal self-regulation tasks, enabling functional
connectomic analyses, can be of benefit in revealing infor-
mation of clinical relevance to Alzheimer’s disease
progression.
During hippocampal downregulation, the decreased EC
in the ACC and primary motor cortex, which is associated
with abnormally decreased CSF amyloid-b42 levels and, by
extension, to increased amyloid-b plaque deposition in the
brain, stands out as a potential neural correlate of elevated
amyloid deposition, particularly because the ACC is among
the first regions where amyloid deposition can be detected
with PET imaging (Grothe et al., 2017). Because of the
characteristics of our sample (Tables 1 and 2), these find-
ings represent early pathophysiological alterations, without
objectively measurable impact on overall memory perform-
ance, that relate to the brain network involved in the regu-
lation of hippocampal hyperactivity. They suggest that in
subjects with abnormal amyloid-b42 deposition, the ACC is
less influential in regulating hippocampal CA1 (adjusted for
risk factors and task performance). According to current
models, the ACC, together with the anterior insula, as
well as parts of the prefrontal cortex, parietal lobule, ven-
tral striatum and thalamus, comprise the brain network
that is primarily responsible for learning to voluntarily
regulate other brain areas through neurofeedback training
(Sitaram et al., 2017). The perspective provide a mechan-
istic explanation for the reason most of these areas, specif-
ically, are engaged by the present VR neurofeedback
paradigm, leading to enhanced sensitivity in relation to
early alterations of their connectivity and systemic network
function.
With elevated CSF p-tau levels, EC decreases in the pre-
frontal cortex and the posterior cingulate cortex, while EC
increases in the ACC and ventral striatum; i.e. during early
stages, amyloid-b42 accumulation in the brain and tau
Figure 2 Correlation between eigenvector centrality during hippocampal downregulation and amyloid-b deposition. The effects
of age, sex, number of APOE e4 alleles, hippocampal volume, cognitive reserve and neurofeedback performance, were modelled and controlled
(z42.326, P50.05 whole-brain corrected, 95% confidence interval). Note that CSF amyloid-b42 levels are inversely proportional to the extent of
amyloid-b plaque deposition in the brain.







aa011/5753887 by guest on 25 February 2020
phosphorylation seem to have opposite effects on EC in the
ACC. The ACC is also involved in the brain signature of
cognitive resilience, which is related to its metabolic cap-
acity (Arenaza-Urquijo et al., 2019). The possibility of EC
in the ACC initially decreasing and later on increasing, in
early response to the subsequent steps of a pathophysio-
logical cascade, resembles the concurrent pattern of default
mode network (DMN) connectivity, which increases pro-
portionally to CSF amyloid-b42 levels within the range of
normal amyloid values, but decreases proportionally to
CSF amyloid-b42 levels within the elevated range of abnor-
mal amyloid accumulation (Palmqvist et al., 2017). This is
supported by the decrease of EC in the posterior cingulate
cortex/precuneus/cuneus that comprises the main DMN
hub (Smith et al., 2009; Andrews-Hanna et al., 2010;
Spreng and Grady, 2010). Moreover, recent evidence sug-
gests that baseline EC in the posterior cingulate cortex/pre-
cuneus region is predictive of first-session DMN
neurofeedback regulation learning (Skouras and
Scharnowski, 2019). Overall, the EC differences associated
with increased CSF p-tau levels and by extension to the
formation of neurofibrillary tangles in the brain, resemble
results found in advanced patients with Alzheimer’s disease
with dementia, in the ACC and occipital cortex
(Binnewijzend et al., 2014). In this context, the present re-
sults corroborate the most relevant literature and support
shifting the timeframe for the detection of aberrant func-
tional alterations, earlier than previously evidenced, to the
presymptomatic stage of Alzheimer’s disease. Of particular
importance, the present findings suggest that aberrant EC
initially precedes neurodegeneration, rather than resulting
from it. This is supported by complementary evidence
showing minimal overlap between the ACC cluster and re-
gions with grey matter reductions in patients with
Alzheimer’s disease (Binnewijzend et al., 2014).
Left BA8, the cluster presenting decreased EC in the left
prefrontal cortex, is one of the main loci of autobiograph-
ical memory (Janata, 2009) and appears to be suitable as
an accessible target region for non-invasive neurostimula-
tion intervention studies (Reinhart and Nguyen, 2019).
Following the interpretational framework proposed by
recent work with resting-state EC and Alzheimer’s disease
CSF biomarkers (Skouras et al., 2019a), given the involve-
ment of the ACC, PFC and ventral striatum in the neuro-
feedback learning network (Sitaram et al., 2017), it is
feasible that the decreasing EC of the PFC is being com-
pensated by increasing EC in the ACC and ventral stri-
atum; the latter of which is affected by amyloid
deposition only at a relatively advanced stage (Grothe
et al., 2017). Considering the crucial roles of the hippocam-
pus, ventral striatum and cingulate in affective processing
(Dalgleish, 2004), these findings support proposing that
Table 3 Results of ECM in relation to CSF biomarkers and age, corrected for whole-brain multiple comparisons
(P50.05)
Brain regions MNI coordinates, x y z Cluster size, mm3 z-value, max (mean)
Amyloid-b correlation with EC during CA1 downregulation
ACC, BA24, BA32 3 24 28 405 –3.34 (–2.65)
L BA4 –21 –27 70 405 –2.73 (–2.49)
R BA4 18 –33 61 594 –2.91 (–2.56)
P-tau correlation with EC during CA1 downregulation
ACC, BA32 (BA10) 12 42 13 513 3.31 ( 2.66)
R Caudate, NAc, Putamen 15 21 –2 513 3.53 ( 2.86)
L Caudate, NAc, Putamen –12 18 –5 756 3.84 ( 2.87)
L BA2 –57 –24 43 297 3.54 ( 2.79)
PCC, PCu, R Cu 21 –66 22 1674 –3.36 (–2.69)
L Frontal pole, BA9 –27 51 43 297 –4.00 (–2.68)
Age correlation with EC during CA1 downregulation
R ITG 57 –54 –23 1539 4.62 (3.01)
R ITG 57 –21 –32 837 3.94 (2.83)
L ITG –63 –45 –20 999 3.38 (2.77)
L ITG –57 –18 –29 459 2.98 (2.65)
MCC, BA24, BA31 –6 –21 43 1593 –4.10 (–2.94)
R BA40, BA2 57 –24 37 2565 –4.26 (–2.83)
L BA40, BA2 –54 –30 28 675 –3.92 (–2.89)
R Insula, BA13 42 6 –5 297 –3.15 (–2.75)
L Insula, BA13 –36 3 –2 648 –3.35 (–2.60)
The fourth column indicates the maximal z-value of voxels within a cluster (with the mean z-value of all voxels within a cluster in parentheses). CSF amyloid-b42 and p-tau levels were
orthogonalized to age, sex, number of APOE e4 alleles, cognitive reserve, brain reserve and hippocampal downregulation performance. For consistency, CSF amyloid-b42 values were
multiplied by –1 during modelling, to align results and colour maps with the direction of the pathophysiological continuum of Alzheimer’s disease. Age was orthogonalized to the CSF
p-tau by amyloid-b42 ratio, sex, number of APOE e4 alleles, cognitive reserve, brain reserve and hippocampal downregulation performance. BA = Brodmann area; Cu = cuneus; L =
left; MCC = midcingulate cortex; MNI = Montreal Neurological Institute; NAc = nucleus accumbens; PCC = posterior cingulate Cortex; PCu = precuneus; p-tau = phosphorylated
tau; R = right.
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some of the earliest effects along the pathophysiological
continuum of Alzheimer’s disease are related to dysfunc-
tions of affective processing, similar to almost all neuro-
psychiatric pathologies (Connan et al., 2003; Leppänen,
2006; Hoekert et al., 2007; Mannie et al., 2007; Kang
et al., 2012). Additionally, in a mouse model of
Alzheimer’s disease, selective neurodegeneration in the ven-
tral tegmental area (VTA) at pre-plaque stages, resulted in
lower dopamine outflow in the hippocampus and nucleus
accumbens and correlated with impairments of synaptic
plasticity in CA1, as well as memory deficits and dysfunc-
tion of reward processing (Nobili et al., 2017). The VTA is
particularly responsive to neurofeedback training
(Macinnes et al., 2016) and outgoing fibres from the
VTA connect directly to the hippocampus (Gasbarri
et al., 1994; Penner and Mizumori, 2012). Thereby, it is
also feasible that the increased EC in the dopaminergic
ventral striatum compensates for early aberrancies in
VTA function that are undetectable with 3 T whole-brain
functional MRI. In addition, a contemporary model pro-
poses that the hippocampus, the prefrontal cortex and the
VTA, form the most crucial components of the long-term
memory network (Penner and Mizumori, 2012).
As hypothesized, during hippocampal downregulation,
cognitively unimpaired subjects with elevated CSF p-tau
levels, exhibit a similar increase in EC, as the one present
during resting state in patients with Alzheimer’s disease
(Binnewijzend et al., 2014), despite important improve-
ments in normalization methods across studies (Avants
et al., 2008; Klein et al., 2009). This corroborates a
Figure 3 Correlation between eigenvector centrality during hippocampal downregulation and CSF p-tau levels. The effects of
age, sex, number of APOE e4 alleles, hippocampal volume, cognitive reserve and neurofeedback performance were modeled and controlled
(z4 2.326, P5 0.05 whole-brain corrected, 95% confidence interval). Note that CSF p-tau levels are proportional to the presence of neuro-
fibrillary tangles in the brain. These results suggest that Alzheimer’s disease-characteristic EC differences in the ACC may occur earlier than
previously believed.
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replicable resting-state finding that was previously only
measurable when investigating across control subjects
and patients with dementia due to Alzheimer’s disease
(Binnewijzend et al., 2014; Skouras et al., 2019a). This
observation suggests that the developed VR neurofeed-
back task may indeed be hypersensitive to preclinical al-
terations in brain function. In contrast, an important
effect of healthy ageing is decreased EC in the cingulate
cortex, during hippocampal downregulation. This corrob-
orates previous evidence from task-free functional MRI,
showing that healthy older adults (mean age = 63, SD =
7) present significantly lower EC in the cingulate than
healthy younger adults (mean age = 24, SD = 4;
Antonenko et al., 2018). Overall, the effect of healthy
ageing on EC across the cingulate cortex (Fig. 4) is op-
posite to that of elevated CSF p-tau levels (Fig. 3), clinical
symptoms (Binnewijzend et al., 2014), and Alzheimer’s
disease progression (Skouras et al., 2019a). Thereby, cur-
rent evidence suggests that the cingulate decreases in cen-
trality in healthy ageing and increases in centrality in
Alzheimer’s disease, with noticeable differences even in
a very early phase. The effect of healthy ageing on EC
in the inferior temporal gyrus, points to the possibility
that in healthy ageing, increasing resources are being
devoted to semantic memory (Binney et al., 2010). To
our knowledge, there is no previous evidence of EC cor-
relation with age in the inferior temporal gyrus; however,
no previous ECM ageing study controlled for the effect of
any CSF biomarkers. Moreover, recent evidence suggests
cognitive decline may emerge from functional decoupling
within a neural circuit composed of temporal and frontal
regions, which is integral to monitoring real-world
Figure 4 Correlation between eigenvector centrality during hippocampal downregulation and age. The effects of sex, number of
APOE e4 alleles, hippocampal volume, cognitive reserve, neurofeedback performance, CSF amyloid-b42 and p-tau levels were modelled and
controlled (z42.326, P50.05 whole-brain corrected, 95% confidence interval). In relation to Fig. 3, these results show that EC in the cingulate
and BA2 present the opposite patterns in healthy ageing.
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information and storing it into memory (Reinhart and
Nguyen, 2019).
In general, the EC findings could be different using a
hippocampal upregulation task, because upregulation and
downregulation learning can be negatively correlated
(Skouras and Scharnowski, 2019). It is important to deter-
mine the specificity of the present findings to hippocampal
downregulation tasks and to replicate them in longitudinal
studies that include both downregulation and upregulation,
as well as sham neurofeedback conditions. It is equally
important to validate the tentative interpretations offered
here, using the same self-regulation paradigm in studies
involving patients with mild cognitive impairment. With
these aims, we have made the developed VR environment
publicly available as open-source software, to enable repli-
cation studies and multicentre investigations within a stand-
ard framework (see ‘Code and data availability’ section).
The latter might enable the aggregation of sufficient data-
sets to derive accurate functional neuroimaging-based diag-
nostic models using machine learning algorithms.
As noted, four participants had a subjective impression
of cognitive or memory decline, while their cognition was
preserved based on objective cognitive testing. These par-
ticipants did not present a consistently distinctive profile
with regards to cognitive scores, hippocampal volume,
genetics or CSF biomarkers. One participant was an
APOE e4 heterozygote with normal biomarkers, one was
an APOE e4 non-carrier with abnormal amyloid-b42 level
but normal p-tau level, one was an APOE e4 non-carrier
with normal amyloid-b42 level but abnormal p-tau level,
and one was an APOE e4 heterozygote with abnormal
amyloid-b42 level and abnormal p-tau level. However, all
four participants were female, with a relatively high level
of education or a relatively high hippocampal downregula-
tion neurofeedback score. Descriptive statistics for these
four participants, in relation to control and preclinical
Alzheimer’s disease participants are provided in
Supplementary Table 2. Based on CSF data from a larger
sample (n = 261) from the ALFA cohort, a subjective im-
pression of cognitive or memory decline is relatively unin-
formative in the context of the present study. Therefore,
we have considered the influence of the four described
participants identically to that of the other participants,
as ordinary instances within the biological and cognitive
variability that exists in the healthy to preclinical range of
the Alzheimer’s disease continuum.
We have demonstrated that amyloid deposition results in
aberrancy with regards to the functional brain network
used to downregulate hippocampal subfield CA1. Further,
significant differences in EC associated with CSF bio-
markers in clinical Alzheimer’s disease, are also measurable
in presymptomatic stages. Moreover, we provide a stand-
ard paradigm to replicate and extend this work on a global
level. This opens new avenues for further research applica-
tions, which quantify and monitor disease progression, by
identifying early alterations in the self-regulation of brain
function, with potential for non-invasive prognostic
screening.
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interpretación. Madrid: Pearson Educación; 2013.
Weiskopf N, Scharnowski F, Veit R, Goebel R, Birbaumer N, Mathiak
K. Self-regulation of local brain activity using real-time functional mag-
netic resonance imaging (fMRI). J Physiol Paris 2004; 98: 357–73.
Wilson IA, Ikonen S, Gureviciene I, McMahan RW, Gallagher M,
Eichenbaum H, et al. Cognitive aging and the hippocampus: how
old rats represent new environments. J Neurosci 2004; 24: 3870–8.
Wink AM, de Munck JC, van der Werf YD, van den Heuvel OA,
Barkhof F. Fast eigenvector centrality mapping of voxel-wise con-
nectivity in functional magnetic resonance imaging: implementation,
validation, and interpretation. Brain Connect 2012; 2: 265–74.
Yushkevich PA, Pluta JB, Wang H, Xie L, Ding SL, Gertje EC, et al.
Automated volumetry and regional thickness analysis of hippocam-
pal subfields and medial temporal cortical structures in mild cogni-
tive impairment. Hum Brain Mapp 2015; 36: 258–87.







aa011/5753887 by guest on 25 February 2020
